Establishment of a Panel for services of preclinical contract research organizations (CROs)
Ireland · how to bid here →
Your path to submission
- Deadline: 31 July 2030 at 12:00 — 1396 days left.
- You submit on eTenders Ireland — not here and not by e-mail. ↗
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (3 awards, most recently May 2021) — by that rhythm the next award was due around July 2021. The last award went to Ipsos B and A.n = 3
- 18% of this buyer's awards went to companies that had already won here before (45 awards since 2013, spread over 33 companies). That is well below the sector norm (31%) — this buyer switches suppliers more often than others.n = 45 awards since 2013
- The median procedure drew 3 bids (45 procedures with a bid count); 20% ended with a single bidder. Sector: median 3 bids.n = 45
- 16% of awards went to companies from abroad (45 awards with a known winner country). Sector average: 15%.n = 45
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Foreign bidders
In Ireland · R&D services, 158 contracts went to foreign companies over the last 3 years (of 1,179 recorded awards) — mostly from France, United Kingdom, Spain.
Typical field: median 2 (from 3 awards).
What the buyer is looking for
RSCI seeks to establish a panel of qualified preclinical contract research organisations (CROs) specialising in disease models to support our early-stage drug discovery and development projects. The chosen CROs will be added to the panel who can provide comprehensive preclinical research services, ensuring rigorous evaluation of potential therapeutic agents in various disease contexts. The successful CROs will be able to offer preclinical services in various areas, including but not limited to the following – applicants may apply if they have expertise in one or more of the following areas: 1. Disease Model Development and Validation; 2. Pharmacological Testing; 3. Efficacy Studies; 4. Safety and Toxicology Testing; 5. Mechanistic Studies; 6. Custom Research Services. The panel will be operational for a six year period and applications can be received at any time during this period, however there is an initial closing date of 31st July 2024.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Hibernian Healthcare Ltd | 3 | 2016–2019 |
| Carl Zeiss Ltd | 3 | 2018–2021 |
| Mason Technology Ltd | 3 | 2020–2022 |
| Laboratory Instrument and Supplies Ltd | 2 | 2020–2022 |
| Illumina Ireland Commercial Limited | 2 | 2014–2024 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.